Views & Analysis
A ghostly undertaking

A ghostly undertaking

As medical ghostwriting comes under increasing scrutiny, Les Rose asks whether the ability to communicate in writing should not be a specialism in its own right. Many years ago I was the project manager of a large clinical study. I ran the study, did most of the data management and a good deal of the analysis, and then left the company for pastures new. Someone else came on board and wrote up the results...

Articles
US healthcare reform’s impact on pharmaceutical sales

US healthcare reform’s impact on pharmaceutical sales

As all eyes focus on the passage of healthcare reform in the United States, Erroin Martin takes a look at how even in America the pharma industry is facing the pain and will need to adapt. The passage of comprehensive healthcare reform will have a dramatic impact on pharmaceutical sales in the United States. The tightening of regulations and product formularies will result in less face-to-face meetings between sales representatives and physicians...

Articles
Twitter use in pharma: valuable or time sinkhole?

Twitter use in pharma: valuable or time sinkhole?

As more and more companies wake up to the reality that Twitter can be a way to reach a large audience, Dr. Andree Bates explores how it is being used and whether it works in pharma or just soaks up time. Current estimates say that Twitter, the microblogging marvel, has a total user count of around 8 million. Every day, up to 10,000 new people join. It’s no wonder that the New York Times calls Twitter “one of the fastest growing phenomena on the Internet.”...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. AbbVie's Cerevel takeover delivers Parkinson's approval
  2. FDA clears first drug for MCT8 deficiency
  3. Novartis taps China's Abogen for autoimmunity TCE
  4. AZ takes stake in Summit Therapeutics in $2bn deal
  5. PhRMA hires ex-House Majority Leader Eric Cantor as its CEO

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more